Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Jazz Pharmaceuticals plc

CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements

The majority of caregivers of patients with tuberous sclerosis complex (TSC) planned to continue Epidiolex treatment, citing benefits like reduced seizure frequency and improvements in cognition and communication. That's according to data from the BECOME-TSC (BEhavior, COgnition, and More with Epidiolex) caregiver survey, revealed by Jazz Pharmaceuticals plc (NASDAQ: JAZZ).…

Benzinga

3 Oncology Stocks With Major Upside

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

StockNews.com

3 Popular Biotech Stocks Offering Solid June Returns

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the surging popularity of plant-based products. Hence, quality biotech stocks, Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Jazz Pharmaceuticals (JAZZ) could be ideal investments for solid returns. Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Biotech Stocks Ready to Surge in June

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

StockNews.com

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

StockNews.com

3 Biotech Gems Poised for April Breakthroughs

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….

StockNews.com

4 A-Rated Biotech Stocks Sparking Investor Interest

The biotech industry is rapidly evolving thanks to the surging biopharma M&A activity and incorporation of new technological trends like AI and gene editing. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Equillium (EQ), Incyte Corporation (INCY), and Jazz Pharmaceuticals plc (JAZZ), rated A (Strong Buy) overall in our…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks to Watch in March for Success

The biotech industry is set for strong growth amid the growing need for personalized treatments, the rising number of chronic diseases, increased investment in research, and the use of advanced technologies. Therefore, investors could consider adding fundamentally strong biotech stocks Acorda Therapeutics (ACOR), BioNTech (BNTX), and Jazz Pharmaceuticals (JAZZ) to…

StockNews.com

Elite 4 Biotech Stocks to Buy Now for Explosive Returns

With a wide range of applications across sectors, including health, agriculture, and industrial processing, rapid technological adoption, and government support, the biotech industry’s prospects appear promising. Thus, investors could consider buying biotech stocks Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Incyte (INCY), and Exelixis (EXEL) for substantial gains. Read on….

StockNews.com

3 Biotech Stock Gems Bursting With Buy Opportunities

The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading….

StockNews.com

3 Biotech Stocks to Buy for Your 2024 Portfolio

The biotech industry is thriving amid innovation, demand, adaptability, and technological advancements, demonstrating resilience and adaptability. So, it could be wise to invest in quality biotech stocks Protalix BioTherapeutics (PLX), Alnylam Pharmaceuticals (ALNY), and Jazz Pharmaceuticals (JAZZ). Read on.

StockNews.com

Top 4 Biotech Stock Buys for 2024 Gains

The biotech industry's dynamic growth, spurred by government backing and technological advances, addresses rising disease challenges and propels advancements in healthcare. Hence, fundamentally strong biotech stocks Gilead Sciences (GILD), Incyte Corporation (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be solid investments for upcoming year gains. Read more….

StockNews.com

3 Biotech Stocks to Boost Portfolios

The biotech sector, fueled by genetic breakthroughs and digital innovations, is witnessing unprecedented growth. Hence, fundamentally sound biotech stocks Genmab (GMAB), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might give a solid boost to one’s portfolio. Keep reading.

StockNews.com

3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)

Breakthrough developments, the use of advanced technologies, and rising investments in R&D are some of the factors driving the growth of the biotech industry. Although BioMarin Pharmaceutical (BMRN) showcases strong growth prospects, investors could consider buying even better biotech stocks Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and Vertex Pharmaceuticals (VRTX). Read…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Promising Biotech Stocks for Smart Investment Strategies

The biotechnology industry is flourishing due to the recent strides in drug formulation, technological advancements, and unwavering government support. Given this backdrop, promising biotech stocks United Therapeutics (UTHR), Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD) present smart investment options to garner significant returns. Read on….

StockNews.com

3 Biotech Stocks With Potential Future Gains

The pharmaceutical industry's inelastic demand provides stability and resilience against economic fluctuations. Moreover, the industry is well positioned to grow steadily thanks to the rising need to treat chronic diseases. Hence, fundamentally sound pharma stocks Shionogi & Co (SGIOY), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) could be ideal buys now.…

StockNews.com

Top 3 Biotech Stocks Leading the Way This October

The biotech industry is well-positioned for strong growth thanks to increasing demand for high-quality treatments for chronic diseases. Given this backdrop, quality biotech stocks Jazz Pharmaceuticals (JAZZ), Amgen (AMGN), and Gilead Sciences (GILD) could be solid buys for October. Read on….

StockNews.com

3 Biotech Stocks to Buy Instead of Palatin Technologies (PTN)

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Best Biotech Stocks for Growth in 2023

The biotech industry is well-positioned for solid growth due to the growing demand for high-quality treatments for chronic diseases and an aging population. Therefore, it could be wise to invest in fundamentally strong biotech stocks Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), and Gilead Sciences (GILD), given their solid growth prospects. Read…

StockNews.com

3 Biotech Stocks to Buy This Month and Beyond

Owing to the critical medical needs, the lookout for new technologies to deal with future advancements is at its peak. Breakthrough innovations, revolutionary treatments, and a booming industry align to make biotech stocks a potential goldmine for savvy investors. Therefore, it could be wise to invest in quality biotech stocks…

StockNews.com

2 Biotech Stocks You Should Buy While You Can, 1 That Investors Are Avoiding

The biotech industry is well-positioned for solid growth, thanks to the rising need for high-quality healthcare and the government's push to increase domestic biotech production and research. To that end, buying fundamentally strong biotech stocks Gilead Sciences (GILD) and Jazz Pharmaceuticals (JAZZ) could be wise. However, it could be prudent…

StockNews.com

3 Biotech Stocks With Strong Value in August

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

StockNews.com

This Mid-Cap Stock Is on Fire, While These 2 Cool Off

Macroeconomic headwinds-induced volatility and the associated recessionary fears are anticipated to linger for a while, even though inflation is cooling down. Given this backdrop, the strong fundamentals of mid-cap stock Jazz Pharmaceuticals (JAZZ) might make it a solid buy. In contrast, fundamentally weak mid-cap stocks Valvoline (VVV) and Axos Financial…

StockNews.com

3 Biotech Stocks With Potential to Be Big Winners in 2023

The biotech industry is well-positioned to grow strongly, given the ever-rising demand for therapies and favorable government initiatives. Looking at the industry’s long-term prospects, fundamentally strong biotech stocks Amgen (AMGN), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) could emerge as big winners this year. Keep reading….

StockNews.com

It’s Time to Buy Up These 3 Growth Stocks In 2023

While higher rates have hurt growth stocks last year, 2023 could be the year of growth stocks gaining momentum. Amid rising optimism, investors could consider buying fundamentally strong growth stocks Gilead Sciences (GILD), Jazz (JAZZ), and Masonite International (DOOR) this year. Keep reading.

1 2

People

Joe Biden

68,093 stories

Dipanjan BanchurSince

722 stories

Sristi Suman JayaswalThe

216 stories

Neha PanjwaniFrom

97 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.